Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 33 recruiting now early-phase tilt #116 of 28,707 conditions

Fatigue: early-phase trial registry

33 of 110 indexed Fatigue trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #116 of 28,707 conditions by registered trial count.

110 US clinical trials · 33 currently recruiting · #116 of 28,707 conditions by registered trial count

Fatigue: 110 US clinical trials tracked, 33 recruiting.

Fatigue is the subject of 110 registered US clinical trials on ClinicalTrials.gov, 33 of them currently open to new participants. 9 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 8 of these trials.

Enrollment posture brief

Registry condition fatigue

OPEN 33 | RECR 30% | LATE 9 | EARLY 21 | RANK #116 | SPON 8

Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)

Quality of Life40.4%Fatigue (this)30%Advanced Malignant Solid Neo24.8%Hepatitis C12%Unspecified Adult Solid Tumo4.5%
Open-enrollment share among volume-matched conditions near Fatigue

Fatigue lists 33 open slots (30% of 110 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fatigue on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fatigue is recruiting below its size-band peers.

    33 of 110 indexed trials (30%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Fatigue trials is spread across many organizations.

    M.D. Anderson Cancer Center accounts for 8 of 110 trials (7.3%). 74 distinct sponsors appear on at least one study for this condition label.

  3. Most Fatigue trials plan to enrol fewer than 100 people.

    Median target enrolment is 64 among the 110 trials that report a genuine target (sentinel values excluded). 70 of those (63.6%) plan for fewer than 100 participants.

  4. Fatigue research is mostly interventional.

    102 interventional and 8 observational studies make up this index (92.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 19Phase 212Phase 37Phase 42

Open and recent trials

110 total, page 2 of 3

COMPLETED NA 500 participants

Radicle Revive 24: A Study of Health and Wellness Products on Menopausal Health and Related Health Outcomes

Radicle Science

NCT06749288

COMPLETED Phase 2 410 participants

Yoga in Treating Sleep Disturbance in Cancer Survivors

Gary Morrow

NCT00397930

COMPLETED Phase 3 376 participants

Levocarnitine in Treating Fatigue in Cancer Patients

ECOG-ACRIN Cancer Research Group

NCT00091169

COMPLETED 367 participants

Evaluation and Diagnosis of People With Pain and Fatigue Syndromes

National Institute of Nursing Research (NINR)

NCT00677157

COMPLETED Phase 3 282 participants

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

NCT00060398

COMPLETED Phase 3 227 participants

(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy

Alliance for Clinical Trials in Oncology

NCT00075842

COMPLETED NA 203 participants

Light Therapy for PD - Dose Selection

Massachusetts General Hospital

NCT04291014

COMPLETED NA 195 participants

Insomnia Self-Management in Heart Failure

Yale University

NCT02660385

COMPLETED NA 194 participants

Systematic Light Exposure for Fatigue in Breast Cancer Patients

Icahn School of Medicine at Mount Sinai

NCT03217201

COMPLETED NA 188 participants

A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer

University of Wisconsin, Madison

NCT01954420

COMPLETED NA 171 participants

Acupressure for Fatigue in Ovarian Cancer Survivors

University of Michigan Rogel Cancer Center

NCT03763838

COMPLETED NA 167 participants

Strong People Strength Training Study

Cornell University

NCT04203563

COMPLETED Phase 3 148 participants

Methylphenidate in Treating Patients With Fatigue Caused by Cancer

Alliance for Clinical Trials in Oncology

NCT00376675

COMPLETED NA 125 participants

Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer

City of Hope Medical Center

NCT00902733

COMPLETED Phase 3 112 participants

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

M.D. Anderson Cancer Center

NCT05041946

COMPLETED 100 participants

Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant

Northside Hospital

NCT01084694

COMPLETED Phase 2 83 participants

Gulf War Illness Inflammation Reduction Trial

Minneapolis Veterans Affairs Medical Center

NCT02506192

COMPLETED 81 participants

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

University of California, San Francisco

NCT00755313

COMPLETED NA 79 participants

Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health

Supplement Formulators

NCT05170113

COMPLETED NA 75 participants

The "PC-LIGHT" Study

Northwestern University

NCT03419585

COMPLETED Phase 3 72 participants

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

The University of Texas Medical Branch, Galveston

NCT03554265

COMPLETED Phase 2 70 participants

Management of Insomnia in Breast Cancer Patients

Stanford University

NCT01011218

COMPLETED NA 68 participants

Stepped-Care Telehealth for Distress in Cancer Survivors

Wake Forest University Health Sciences

NCT03060096

COMPLETED Phase 3 67 participants

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Alliance for Clinical Trials in Oncology

NCT00040885

COMPLETED Early Phase 1 64 participants

Muscadine Grape Extract to Improve Fatigue

Wake Forest University Health Sciences

NCT04495751

COMPLETED NA 55 participants

Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study

St. Jude Children's Research Hospital

NCT02429063

COMPLETED NA 54 participants

Treating Cancer-Related Fatigue Through Systematic Light Exposure

Icahn School of Medicine at Mount Sinai

NCT01873794

COMPLETED Phase 1 54 participants

Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients

University of Pittsburgh

NCT00177840

COMPLETED NA 50 participants

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

SWOG Cancer Research Network

NCT01453452

COMPLETED NA 45 participants

Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

University of Michigan

NCT02495155

COMPLETED NA 44 participants

The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older

UNC Lineberger Comprehensive Cancer Center

NCT02191982

COMPLETED NA 44 participants

Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer

Vanderbilt-Ingram Cancer Center

NCT00574145

COMPLETED NA 42 participants

The Effect of Aroma on Fatigue Scores Among Women With Hypothyroidism

Nutraceuticals Research Institute

NCT03465176

COMPLETED NA 40 participants

The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study

Bioenergy Life Science

NCT00821067

COMPLETED NA 37 participants

MS Symptom Management Study

University of Washington

NCT02474940

COMPLETED NA 36 participants

Effectiveness of 10-minute Chair Massage Versus 10-minute Break to Reduce Stress and Improve Well-being

Geisinger Clinic

NCT04787107

COMPLETED NA 35 participants

Effect of Beta-Alanine on Heart Rate Response

University of North Carolina, Chapel Hill

NCT01745016

COMPLETED NA 35 participants

Support for Caregivers of Older Adults With Cognitive Decline

State University of New York at Buffalo

NCT04787068

COMPLETED NA 33 participants

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Ohio State University Comprehensive Cancer Center

NCT01929720

COMPLETED NA 31 participants

KAM: Kids Are Moving

University of Minnesota

NCT02626637

COMPLETED Phase 1 31 participants

Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate

M.D. Anderson Cancer Center

NCT02361125

COMPLETED NA 30 participants

CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue

Medical University of South Carolina

NCT03149094

COMPLETED Phase 1 30 participants

Art and Surface Electromyography (EMG)

Logan College of Chiropractic

NCT00731991

COMPLETED NA 29 participants

Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)

Stanford University

NCT01536977

COMPLETED NA 26 participants

Alterations in Gait, Strength, and Power After Ruck Marching

State University of New York at Buffalo

NCT05309603

COMPLETED NA 24 participants

Effects of Muscle Fatigue and Kinesio Taping on Shoulder Position Sense

University of Oregon

NCT02104570

COMPLETED Phase 2 21 participants

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

NCT00005850

COMPLETED Phase 1 18 participants

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Pfizer

NCT04803305

COMPLETED NA 18 participants

Vagal Nerve Stimulation for Post COVID Fatigue

Mayo Clinic

NCT05445427

COMPLETED NA 16 participants

Virtual Reality Meditation for Fatigue

University of Washington

NCT04804462

← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 9
Phase 2 12
Phase 3 7
Phase 4 2

Named interventions

Most-linked intervention names on Fatigue records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

questionnaire administration Other
4 trials
placebo Other
4 trials
Placebo Drug
4 trials
quality-of-life assessment Procedure
3 trials
Methylphenidate Drug
3 trials
Attention Control Other
3 trials
laboratory biomarker analysis Other
3 trials
fatigue assessment and management Procedure
2 trials

US sites by state

Facility locations filed on Fatigue trials. A trial with sites in several states counts in each.

California 19 trials
Texas 13 trials
Maryland 12 trials
New York 11 trials
Illinois 11 trials
North Carolina 10 trials
Florida 10 trials
Colorado 9 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fatigue page

110 registered trials, 33 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fatigue condition card totals 110 registered trials; most-linked intervention questionnaire administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.